Magnetic Resonance Imaging in the Staging of Hodgkin’s Disease and Non-Hodgkin Lymphoma

Author(s):  
J. D. Tesoro-Tess ◽  
L. Balzarini ◽  
E. Ceglia ◽  
R. Petrillo ◽  
Y. Reyner ◽  
...  
1991 ◽  
Vol 12 (2) ◽  
pp. 81-90 ◽  
Author(s):  
John D. Tesoro-Tess ◽  
Luca Balzarini ◽  
Errico Ceglia ◽  
Raffaele Petrillo ◽  
Armando Santoro ◽  
...  

1987 ◽  
Vol 28 (2) ◽  
pp. 145-151 ◽  
Author(s):  
Rickard Nyman ◽  
S. Rehn ◽  
B. Glimelius ◽  
H. Hagberg ◽  
A. Hemmingsson ◽  
...  

2009 ◽  
Vol 33 (3) ◽  
pp. 466-474 ◽  
Author(s):  
Maija Rossi ◽  
Prasun Dastidar ◽  
Hannu Pertovaara ◽  
Ritva Järvenpää ◽  
Tiina Luukkaala ◽  
...  

1987 ◽  
Vol 28 (2) ◽  
pp. 145-151 ◽  
Author(s):  
R. Nyman ◽  
S. Rehn ◽  
B. Glimelius ◽  
H. Hagberg ◽  
A. Hemmingsson ◽  
...  

Six patients with mediastinal involvement of Hodgkin's disease were examined with magnetic resonance imaging (MRI) at 0.35 T before and/or at various stages of therapy, with the sequences TR/TE: 500/35, 500/70, 1600/35 and 1600/70. Before therapy the image intensity of tumour involved lymph nodes deviated considerably from fat and muscle, but no clear difference was discerned between histopathologic subtypes or tumour localizations. After efficient therapy, the tumour image intensities and relaxation rates approached those of muscle and fibrous tissue, but remained at pre-therapy values when the patient was not in full remission. A similar pattern was found in a ‘normal-tissue’—‘tumour’ plot, based on vector analysis of the original sets of 4 images. It is concluded that persistent tumour involvement in the mediastinum may be distinguished from fibrosis and that MRI may thus be of value in the follow-up of patients with Hodgkin's disease.


Sign in / Sign up

Export Citation Format

Share Document